WPI 3631 (Hydromorphone Hydrochloride Extended-Release 32 mg)
Pill with imprint WPI 3631 is White, Round and has been identified as Hydromorphone Hydrochloride Extended-Release 32 mg. It is supplied by Actavis Pharma, Inc..
Hydromorphone is used in the treatment of chronic pain; pain; cough; anesthetic adjunct and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Hydromorphone 32 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 3631
Hydromorphone Hydrochloride Extended-Release
- Imprint
- WPI 3631
- Strength
- 32 mg
- Color
- White
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Narcotic analgesics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-3631
- Inactive Ingredients
-
cellulose acetate,
copovidone,
hypromelloses,
ferrosoferric oxide,
lactose monohydrate,
magnesium stearate,
polyethylene glycol,
propylene glycol,
sodium chloride,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
More about hydromorphone
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- 408 Reviews
- Drug class: narcotic analgesics
- FDA Alerts (10)
Consumer resources
- Patient Information
- Hydromorphone injection
- Hydromorphone rectal
- Hydromorphone (Advanced Reading)
- Hydromorphone Injection (Advanced Reading)
- Other brands
- Dilaudid, Dilaudid-HP, Palladone, Exalgo
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.